๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Lymphoma, T Cell, Peripheral

Pembrolizumab and Olaparib Treatment for Relapsed or Refractory Peripheral T-Cell Lymphoma NCT06160843Phase 21 site๐Ÿ“ Singapore National Cancer Centre, Singapore ยท Tests: Pembrolizumab IV infusion Q3W, with daily oral Olaparib. Real-life Experience of Brentuximab Vedotin Plus CHP as First-line Treatment of CD30+ Peripheral T-cell Lymphomas in Spain NCT07624838n/a37 sites๐Ÿ“ A Coruรฑa๐Ÿ“ Palma de Mallorca๐Ÿ“ Palma de Mallorca Grupo Espaรฑol de Linfomas y Transplante Autรณlogo de Mรฉdula โ€ฆ ยท Tests: Brentuximab Vedotin Plus CHP A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies NCT07195916Phase 122 sites๐Ÿ“ Duarte๐Ÿ“ La Jolla๐Ÿ“ Ann Arbor Incyte Corporation ยท Tests: INCA036873 Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors NCT02508038Phase 11 site๐Ÿ“ Madison University of Wisconsin, Madison ยท Tests: TCRฮฑฮฒ+/CD19+ depleted Haploidentical HSCT, Zoledronate A Phase I/II Study of OJP-001 in Patients With Adult T-cell Leukemia/Lymphoma NCT07075328Phase 1, Phase 25 sites๐Ÿ“ Fukuoka๐Ÿ“ Sapporo๐Ÿ“ Kagoshima Otsuka Medical Devices Co., Ltd. Japan ยท Tests: Drug:5-ALA, Device:Photodynamic system AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies. NCT06137144Phase 1, Phase 238 sites๐Ÿ“ Duarte๐Ÿ“ Miami๐Ÿ“ Atlanta AstraZeneca ยท Tests: AZD3470, Pembrolizumab A Study of Duvelisib Versus Gemcitabine or Bendamustine in Participants With Relapsed/Refractory Nodal T Cell Lymphoma With T Follicular Helper (TFH) Phenotype NCT06522737Phase 344 sites๐Ÿ“ Ghent๐Ÿ“ Leuven๐Ÿ“ Prague SecuraBio ยท Tests: Duvelisib, Gemcitabine, Bendamustine DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers NCT05770037Phase 2, Phase 327 sites๐Ÿ“ Belfast๐Ÿ“ Birmingham๐Ÿ“ Birmingham Cancer Research UK ยท Tests: Alectinib Sintilimab Combined With Chidamide in Treating Peripheral T Cell Lymphoma NCT04512534Phase 21 site๐Ÿ“ Shanghai Fudan University ยท Tests: PD-1 antibody+ HDAC inhibitor Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma NCT04803201Phase 296 sites๐Ÿ“ Little Rock๐Ÿ“ Duarte๐Ÿ“ La Jolla Alliance for Clinical Trials in Oncology ยท Tests: Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, Etoposide Polyspecific Antibodies in Lymphoproliferative T-cell Disorders NCT06495723Phase 1, Phase 28 sites๐Ÿ“ Caen๐Ÿ“ Clermont-Ferrand๐Ÿ“ Crรฉteil Xenothera SAS ยท Tests: LIS1 Dolutegravir Versus Dolutegravir in Combination With Tenofovir for the Treatment of HTLV-1 Infection NCT07555431Phase 21 site๐Ÿ“ Salvador Carlos Brites ยท Tests: Combination of Dolutegravir + Tenofovir DF for treatment of HTLV-1 infection, Dolutegravir (DTG) Exploratory Clinical Study of SHR-0302 and SHR-2554 in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma NCT06519526Phase 21 site๐Ÿ“ Shanghai Fudan University ยท Tests: SHR-0302, SHR-2554 Transplantation After Complete Response In Patients With T-cell Lymphoma NCT05444712NA48 sites๐Ÿ“ Amiens๐Ÿ“ Angers๐Ÿ“ Argenteuil Hospices Civils de Lyon ยท Tests: Chemotherapy + follow up, Chemotherapy + ASCT + follow up Chidamide Combined With Brentuximab Vedotin Regimen for CD30+ PTCL Patients NCT07074457NA1 site๐Ÿ“ Suzhou The First Affiliated Hospital of Soochow University ยท Tests: Induction therapy-3 cycles of BvC (Brentuximab vedotin plus Chidamide), Consolidation therapy- 3 or 6 cycles of BvC(Breโ€ฆ Adaptive Dual-Target CAR-T Cells for Relapsed or Refractory Hematologic Malignancies NCT07523555Phase 1, Phase 21 site๐Ÿ“ Shenzhen Beijing Biotech ยท Tests: Autologous CD19/CD22 dual-target CAR-T module, Autologous CD19/CD20 dual-target CAR-T module, Autologous BCMA/CD19 dualโ€ฆ Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) NCT06810778Phase 1, Phase 21 site๐Ÿ“ Los Angeles Jonsson Comprehensive Cancer Center ยท Tests: Duvelisib, Venetoclax Treatment of Relapsed or Refractory B-cell Lymphoma With Chimeric Antigen Receptor (CAR) T-cell Therapy Produced by a New Technology NCT06378190Phase 1, Phase 28 sites๐Ÿ“ Barcelona๐Ÿ“ L'Hospitalet de Llobregat๐Ÿ“ Madrid Instituto de Investigaciรณn Biomรฉdica de Salamanca ยท Tests: CAR-T cells therapy Amping up With PemJAK NCT07283822Phase 21 site๐Ÿ“ New York Seda S. Tolu ยท Tests: Ruxolitinib, Pembrolizumab An Open-label, Single-arm, Multicenter Phase II Clinical Study of Azacitidine, Chidamide Combined With PD-1 Monoclonal Antibody in the Treatment of Refractory/Relapsed Peripheral T-cell Lymphoma. NCT07598578EARLY Phase 11 site๐Ÿ“ Suzhou Second Affiliated Hospital of Soochow University ยท Tests: Azacitidine (AZA) Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS) NCT03970096Phase 23 sites๐Ÿ“ Tampa๐Ÿ“ Pittsburgh๐Ÿ“ Seattle Fred Hutchinson Cancer Center ยท Tests: Total-Body Irradiation, Thiotepa, Fludarabine, Tacrolimus, Allogeneic CD34+-enriched and CD45RA-depleted PBSCs A Randomized Clinical Trial Comparing Chi-BEAM With BEAM Regimen Combined With ASCT for the Treatment of ND PTCL NCT05931263Phase 31 site๐Ÿ“ Nanjing The First Affiliated Hospital with Nanjing Medical Universiโ€ฆ ยท Tests: C-BEAM Regimen, BEAM Regimen Auto Stem Cell Transplant for Lymphoma Patients NCT03125642Phase 21 site๐Ÿ“ Minneapolis Masonic Cancer Center, University of Minnesota ยท Tests: Etoposide, BCNU, AraC, Melphalan, Peripheral blood stem cell transplantation A Pilot of a Microdevice For In Situ Candidate Drug Screening in Cutaneous Lesions of T-Cell Lymphoma NCT04045470NA1 site๐Ÿ“ Boston Dana-Farber Cancer Institute ยท Tests: Microdevices, Standard of care therapy, Standard of care systemic therapy To Observe the CD7-targeted CAR-T Therapy in the Treatment of r/r PTCL NCT07143929Phase 11 site๐Ÿ“ Beijing Peking University People's Hospital ยท Tests: CAR-T CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma NCT04083495Phase 22 sites๐Ÿ“ Chapel Hill๐Ÿ“ Winston-Salem UNC Lineberger Comprehensive Cancer Center ยท Tests: ATLCAR.CD30 T cells, Bendamustine, Fludarabine, Cyclophosphamide Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution NCT06131801n/a6 sites๐Ÿ“ Aurora๐Ÿ“ Atlanta๐Ÿ“ Cincinnati Children's Hospital Medical Center, Cincinnati ยท Tests: 1. Drug: The Venetoclax PK study is collecting bodily fluid samples (ie., whole blood and optional cerebrospinal fluid)โ€ฆ Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies NCT04068597Phase 1, Phase 239 sites๐Ÿ“ Atlanta๐Ÿ“ Indianapolis๐Ÿ“ Bethesda CellCentric Ltd. ยท Tests: CCS1477, Pomalidomide, Dexamethasone, Azacitidine, Venetoclax Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma NCT06561048Phase 337 sites๐Ÿ“ Duarte๐Ÿ“ Irvine๐Ÿ“ San Francisco Corvus Pharmaceuticals, Inc. ยท Tests: Soquelitinib, Belinostat, Pralatrexate Sample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin Lymphoma (SCORE-NHL) NCT07750886n/a1 site๐Ÿ“ Austin Natera, Inc.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy